铂耐药或难治性卵巢癌最佳支持治疗和二线化
2018-4-16 来源：本站原创 浏览次数：次AsianPacJCancerPrev.;17(2):-.
CostEffectivenessAnalysisofDifferentManagementStrategiesbetweenBestSupportiveCareandSecond-lineChemotherapyforPlatinum-resistantorRefractoryOvarianCancer.
LuealonP,KhempechN,VasuratnaA,HanvoravongchaiP,HavanondP.
DepartmentofObstetricsandGynecology,FacultyofMedicine,ChulalongkornUniversity,Bangkok,Thailand.
BACKGROUND:Thereisnostandardtreatmentforpatientswithplatinum-resistantorrefractoryepithelialovariancancer.Singleagentchemotherapieshaveevidenceofmoreefficacyandlesstoxicitythan北京正规白癜风医院哪家医院看白癜风比较好
健康热线：